Advanced method for determination of omeprazole in plasma by HPLC

Arch Pharm Res. 1999 Feb;22(1):86-8. doi: 10.1007/BF02976443.

Abstract

An advanced and sensitive high-performance liquid chromatographic (HPLC) method for determination of omeprazole in human plasma has been developed. After omeprazole was extracted from plasma with diethylether, the organic phase was transferred to another tube and trapped back with 0.1 N NaOH solution. The alkaline aqueous layer was injected into a reversed-phase C8 column. Lansoprazole was used as an internal standard. The mobile phase consisted of 30% of acetonitrile and 70% of 0.2 M KH2P04, pH 7.0. Recoveries of the analytes and internal standard were >75.48%. The coefficients of variation of intra- and inter-day assay were <5.78 and 4.59% for plasma samples. The detection limit in plasma was 2 ng/ml. The clinical applicability of this assay method was evaluated by determining plasma concentration-time courses of the respective analytes in 24 healthy volunteers after oral administration 40 mg of omeprazole. The present assay is considered to be simple, accurate, economical and suitable for the study of the kinetic disposition of omeprazole in the body.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Ulcer Agents / blood*
  • Anti-Ulcer Agents / pharmacokinetics
  • Area Under Curve
  • Calibration
  • Chromatography, High Pressure Liquid
  • Half-Life
  • Humans
  • Omeprazole / blood*
  • Omeprazole / pharmacokinetics
  • Spectrophotometry, Ultraviolet

Substances

  • Anti-Ulcer Agents
  • Omeprazole